The X Prize Foundation has appointed Leena Peltonen to the scientific advisory board of the Archon X Prize for Genomics.
Peltonen is a professor at the University of Helsinki and at the National Public Health Institute in Finland, and is a visiting professor at the Broad Institute of MIT and Harvard.
US Genomics announced that Craig Venter has stepped down from its board of directors and that Salvatore Salamone has joined it.
Salamone is currently chairman and CEO of Saladax BioMedical, a developer of chemotherapy-monitoring assays. Previously, he was vice president of R&D at Roche Diagnostics and senior vice president of R&D at Orasure Technologies.
Qiagen has nominated Heino von Prondzynski and Werner Brandt to the company’s supervisory board. They will stand for election at Qiagen’s annual meeting June 20.
Also at that meeting, Franz Wirtz and Heinrich Hornef will retire from their long-held positions on the company’s supervisory board.
Prondzynski was CEO of Roche Diagnostics and a member of Roche’s executive committee and was CEO and general manager at Chiron.
Brandt was chief financial officer at SAP and was a member of SAP’s executive board. He also was CFO of Frenesius Medical Care and formerly worked in finance at Price Waterhouse Coopers.
Ciphergen has named Steve Lundy senior vice president of sales and marketing, the company said last week.
Lundy comes to Ciphergen from GeneOhm, where he was vice president of sales and marketing. He had worked earlier as vice president of marketing at Esoterix and was marketing director of molecular diagnostics and critical care testing at Bayer Diagnostics.